anti-ADAM17/anti-B7H3 TriKE-PACC

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug Nameanti-ADAM17/anti-B7H3 TriKE-PACC

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Biologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionAnti-CD276Disintegrin and metalloproteinase domain-containing protein 17 inhibitors

TargetsCD276 antigenDisintegrin and metalloproteinase domain-containing protein 17

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Minnesota

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Minnesota

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A